We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$88B
AUM Growth
+$3.05B
(+3.6%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-3.73%
Top 10 Holdings %
Top 10 Hldgs %
12.89%
Holding
2,253
New
146
Increased
815
Reduced
1,092
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$267M |
| 2 |
Home Depot
HD
|
+$252M |
| 3 |
Northrop Grumman
NOC
|
+$221M |
| 4 |
Gilead Sciences
GILD
|
+$175M |
| 5 |
Dollar General
DG
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$287M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$278M |
| 3 |
Biogen
BIIB
|
+$244M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$198M |
| 5 |
Exelon
EXC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.05% |
| 2 | Financials | 14.3% |
| 3 | Healthcare | 13.64% |
| 4 | Consumer Discretionary | 13.24% |
| 5 | Industrials | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Monro
MNRO
$398M
| $316K | ﹤0.01% |
4,038
-7,534
| -65% | -$568K |
|
1902
Harley-Davidson
HOG
$2.71B
| $315K | ﹤0.01% |
8,477
-14,481
| -63% | -$539K |
|
|
COOP
1903
DELISTED
Mr. Cooper
COOP
| $310K | ﹤0.01% |
24,741
-10,683
| -30% | -$131K |
|
1904
Lakeland Financial Corp
LKFN
$1.53B
| $310K | ﹤0.01% |
6,341
+912
| +17% | +$42.4K |
|
|
WPX
1905
DELISTED
WPX Energy, Inc.
WPX
| $310K | ﹤0.01% |
22,620
-228,857
| -91% | -$2.44M |
|
1906
Bally's
BALY
$658M
| $309K | ﹤0.01% |
+12,035
| New | +$290K |
|
1907
Lumen
LUMN
$6.44B
| $308K | ﹤0.01% |
23,469
-36,808
| -61% | -$494K |
|
1908
OceanFirst Financial
OCFC
$1.91B
| $303K | ﹤0.01% |
11,856
-1,990
| -14% | -$47.9K |
|
1909
Radiant Logistics
RLGT
$395M
| $303K | ﹤0.01% |
54,406
-58,805
| -52% | -$318K |
|
1910
Mesa Laboratories
MLAB
$574M
| $298K | ﹤0.01% |
1,194
-236
| -17% | -$55.3K |
|
1911
Stratasys
SSYS
$774M
| $298K | ﹤0.01% |
14,731
-17,575
| -54% | -$350K |
|
1912
Alaunos Therapeutics
TCRT
$4.86M
| $297K | ﹤0.01% |
419
+88
| +27% | +$60.6K |
|
1913
Ameresco
AMRC
$1.36B
| $296K | ﹤0.01% |
16,921
-6,415
| -27% | -$101K |
|
1914
Houlihan Lokey
HLI
$9.02B
| $295K | ﹤0.01% |
+6,040
| New | +$285K |
|
1915
Dycom Industries
DY
$12.3B
| $293K | ﹤0.01% |
6,224
+1,001
| +19% | +$48.7K |
|
|
AGEN
1916
Agenus
AGEN
$290M
| $291K | ﹤0.01% |
3,642
+2,094
| +135% | +$141K |
|
|
DEA
1917
Easterly Government Properties
DEA
$1.18B
| $289K | ﹤0.01% |
+4,879
| New | +$275K |
|
|
ODT
1918
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $289K | ﹤0.01% |
+8,909
| New | +$276K |
|
|
LORL
1919
DELISTED
Loral Space and Communications, Inc.
LORL
| $289K | ﹤0.01% |
8,928
+316
| +4% | +$11.6K |
|
|
EXTN
1920
DELISTED
Exterran Corporation
EXTN
| $288K | ﹤0.01% |
36,779
+22,508
| +158% | +$209K |
|
1921
Ardelyx
ARDX
$997M
| $283K | ﹤0.01% |
+37,649
| New | +$229K |
|
|
RRD
1922
DELISTED
RR Donnelley & Sons Co.
RRD
| $283K | ﹤0.01% |
71,527
-33,922
| -32% | -$134K |
|
1923
Kadant
KAI
$3.99B
| $282K | ﹤0.01% |
2,676
+302
| +13% | +$28.7K |
|
1924
S&T Bancorp
STBA
$1.79B
| $281K | ﹤0.01% |
6,974
+542
| +8% | +$20.5K |
|
1925
DigitalBridge
DBRG
$2.95B
| $277K | ﹤0.01% |
+14,592
| New | +$301K |
|
Similar funds
VGA
AQR Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, AQR Capital Management held 2,253 positions worth $88B, up 3.6% from $84.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management withdrew a net $3.28B in Q4 2019, closing 142 positions and reducing 1,092 holdings. Its most notable exit was iShares Russell 3000 ETF, an estimated $198M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, AQR Capital Management opened a new position in DaVita worth $31.1M.
- AQR Capital Management's largest Q4 2019 buy was DaVita: 417,883 shares worth $31.1M.
- AQR Capital Management added most to Humana in Q4 2019, an estimated $267M increase.
- AQR Capital Management's biggest Q4 2019 reduction was HP, cutting an estimated $287M.
- AQR Capital Management fully exited iShares Russell 3000 ETF in Q4 2019, selling an estimated $198M.
- AQR Capital Management's ten largest holdings make up 13% of its $88B portfolio in Q4 2019.
- AQR Capital Management opened 146 new positions and closed 142 in Q4 2019.
- AQR Capital Management's portfolio value rose 3.6% quarter-over-quarter to $88B.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.